Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Diaceutics PLC logo — Better Testing, Better Treatment

Diaceutics PLC

Better Testing, Better Treatment

Founded 2005 United Kingdom United Kingdom 199 employees Post-IPO Debt Total: $8.30M Analytics, Biotechnology +2

General Information

Company Name Diaceutics PLC
Founded Year 2005
Location United Kingdom United Kingdom
Founders / Decision Makers
Team member
Employees 199
Industries Analytics, Biotechnology, Health Care +1
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Diaceutics PLC. To contact Diaceutics PLC, visit diaceutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Diaceutics PLC compare?

A PDF of Diaceutics PLC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Diaceutics PLC soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Diaceutics PLC

Diaceutics PLC is a United Kingdom-based biotechnology and pharmaceutical company that was founded in 2005. The company's slogan, "Better Testing, Better Treatment," reflects its core mission of ensuring that every patient receives the right treatment at the right time. Diaceutics offers an end-to-end solution to pharmaceutical companies for launching precision medicine diagnostics through its innovative DXRX platform, known as The Diagnostic Network®. This platform, DXRX, is a pioneering diagnostic commercialization platform for precision medicine, uniquely integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. The company has garnered significant attention from investors, with its last investment being a substantial £4.00MPost-IPO Debt investment, which took place on 26 August 2020. Notably, this investment was secured from Silicon Valley Bank. In summary, Diaceutics PLC has positioned itself at the forefront of precision medicine, providing valuable support to pharmaceutical companies. With its innovative platform and strong investor backing, the company is well-positioned to continue driving advancements in the field of diagnostic testing and precision medicine.

Business keywords: precision medicine, diagnostics, pharmaceutical industry, DXRX, real-world testing data, laboratory network, diagnostic commercialization, personalized medicine, treatment pathways, commercial planning, diagnostic landscape, return on investment, global network, test implementation, patient treatment decisions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt £4.00M 1
Silicon Valley Bank
26 Aug 2020
Venture Round €4.30M 2
Whiterock Capital
Whiterock Capital, Silicon Valley Bank
05 Apr 2018

Diaceutics PLC Alternatives & Competitors

View All Alternatives
Diaceutics PLC vs
XO Life
XO Life Germany

Building brite™, the patient-pharma platform turning therapy support into real-world evidence 🌎

38 employees
Biotechnology, Pharmaceutical
Compare Diaceutics PLC vs XO Life
Diaceutics PLC vs
Selah Genomics Inc
Selah Genomics Inc United States

Selah Genomics is a personalized medicine diagnostic specialist supporting healthcare providers and...

Debt Financing
1 employees
Biotechnology, Health Care
Compare Diaceutics PLC vs Selah Genomics Inc
Diaceutics PLC vs
mdxhealth
mdxhealth United States

Molecular Diagnostic Solutions for Prostate Cancer

Post-IPO Equity
262 employees
Biotechnology, Health Care
View all alternatives

FAQ About Diaceutics PLC

Better Testing, Better Treatment
Diaceutics PLC was founded in 2005.
Diaceutics PLC is headquartered in United Kingdom.
Diaceutics PLC operates in Analytics, Biotechnology, Health Care and Pharmaceutical. Its work centres on precision medicine, diagnostics, pharmaceutical industry and DXRX.
Diaceutics PLC has approximately 199 employees.
Diaceutics PLC has completed 2 funding rounds, raising a total of $8.30M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Diaceutics PLC include XO Life, Selah Genomics Inc, mdxhealth, Metamark Genetics, PreBiomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diaceutics PLC and XO Life are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Diaceutics PLC, https://bouncewatch.com/company/diaceutics-plc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout